严重精神疾病对芬兰肺癌患者癌症特异性死亡率的影响:1990-2013年登记队列研究
该芬兰登记队列研究纳入1990-2013年37,852例首次诊断肺癌患者,其中12%有严重精神疾病(SMI)病史,采用竞争风险分析比较癌症特异性死亡率。控制分期和治疗后,部分肺癌类型中SMI患者死亡率更高,如精神病男性鳞癌HR=1.24(1.06-1.45),精神病女性小细胞癌HR=1.76(1.41-2.19)等;五年死亡率HR差异自1990年代以来无明显变化。结论提示需加强精神卫生与肿瘤团队协作以缩小死亡率差距。
要点
- 12%肺癌患者有SMI病史,部分亚型癌症特异性死亡率显著升高。
- 精神病女性小细胞癌HR=1.76(1.41-2.19),鳞癌HR=1.67(1.26-2.20)。
- 需精神卫生与肿瘤团队协作缩小死亡率差距。
核心结论
- 有严重精神疾病病史的肺癌患者癌症特异性死亡率升高。
- 需患者、精神卫生专业人员和肿瘤团队协作以缩小死亡率差距。
研究设计与样本
- 基于芬兰癌症登记、医院出院登记和死因统计的登记队列研究。
- 纳入1990-2013年首次诊断肺癌患者37,852例,12%有SMI病史。
- 采用竞争风险分析估计SMI对死亡率的风险比(HR)。
主要发现
- 控制分期和治疗后,部分肺癌类型中SMI患者癌症特异性死亡率存在差异。
- 精神病男性鳞状细胞癌HR=1.24(1.06-1.45)。
- 精神病女性小细胞癌HR=1.76(1.41-2.19),鳞状细胞癌HR=1.67(1.26-2.20)。
- 情绪障碍女性腺癌HR=1.37(1.08-1.74)。
- 五年死亡率HR的患者组间差异自1990年代以来无明显变化。
临床怎么用
- 对肺癌患者应关注严重精神疾病病史,识别高死亡风险亚组。
- 建议精神卫生专业人员与肿瘤团队协作管理合并SMI的肺癌患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although the link between severe mental illness (SMI) and elevated cancer mortality is well established, few studies have examined lung cancer survival and SMI in detail. Our study compared cancer-specific mortality in patients with lung cancer with and without a history of SMI and analysed whether mortality differences could be explained by cancer stage at presentation, comorbidity or differences in cancer treatment. METHODS: We identified patients with their first lung cancer diagnosis in 1990-2013 from the Finnish Cancer Registry, their preceding hospital admissions due to SMI from the Hospital Discharge Register and deaths from the Causes of Death statistics. Competing risk analyses were used to estimate hazard ratios (HRs) for the impact of SMI on mortality. RESULTS: Of the 37,852 lung cancer cases, 12% had a history of SMI. Cancer-specific mortality differences were found between patient groups in some cancer types after controlling for stage at representation and treatment. Men with a history of psychosis had excess mortality risk (HR = 1.24, 1.06-1.45) in squamous cell carcinoma. Similar excess risk was found among women with psychosis in small-cell carcinoma (HR = 1.76, 1.41-2.19) and in squamous cell carcinoma (HR = 1.67, 1.26-2.20) and among women with mood disorders in adenocarcinoma (HR = 1.37, 1.08-1.74). Patient group differences in HRs in five-year mortality did not markedly change from the 1990s. CONCLUSIONS: We found elevated cancer-specific mortality among persons with a history of SMI. Collaboration between patients, mental healthcare professionals and oncological teams is needed to reduce the mortality gap between patients with cancer with and without SMI.
引用
- Arffman M, Manderbacka K, Suvisaari J, et al. The impact of severe mental illness on lung cancer mortality of patients with lung cancer in Finland in 1990-2013: a register-based cohort study. Eur J Cancer. 2019. PMID: 31326729. doi:10.1016/j.ejca.2019.06.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。